My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Exact Sciences Corporation - Common Stock (NQ:EXAS)

103.24 +0.01 (+0.01%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Why Is Exact Sciences Stock Trading Higher On Monday? ↗

November 26, 2024

Centers for Medicare & Medicaid Services finalizes 2025 pricing for Exact Sciences' Cologuard Plus, raising Medicare reimbursement by 16% and boosting growth projections for next year.

Via Benzinga

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

November 26, 2024

Via Benzinga

US Stocks May Have A Slow Start As Trump's Tariff Threat Begins To Thwart Relief Rally: Analysts Remain Optimistic About AI-Linked Sectors Stocks ↗

November 26, 2024

U.S. stocks could open on a sluggish note on Tuesday after ending in green on Monday as President-elect Donald Trump threatened to hit two of U.S.'s largest trading partners - Canada and Mexico - with...

Via Benzinga

Topics Government

Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? ↗

November 06, 2024

The company reported lighter-than-expected third-quarter sales due to issues with physician order rates.

Via Investor's Business Daily

Will EXACT SCIENCES CORP breakout? ↗

October 30, 2024

With a solid technical rating of 8 out of 10, EXACT SCIENCES CORP (NASDAQ:EXAS) is showing strong indications of a possible breakout.

Via Chartmill

Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings) ↗

October 29, 2024

Via Benzinga

(EXAS) - Analyzing Exact Sciences's Short Interest ↗

October 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 06, 2024

Via Benzinga

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point ↗

November 06, 2024

Exact Sciences Q3 EPS loss of $0.21 fell short of analyst expectations. 2024 revenue guidance lowered amid screening segment hurdles, growth plans set for 2025.

Via Benzinga

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

Analyst Ratings For Exact Sciences ↗

October 01, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Exact Sciences ↗

September 12, 2024

Via Benzinga

Exact Sciences Analysts Slash Their Forecasts After Q2 Results ↗

August 01, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

November 06, 2024

Via Benzinga

Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript ↗

November 05, 2024

EXAS earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates ↗

November 05, 2024

Exact Sciences shares are dropping after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the details.

Via Benzinga

Can This Beaten-Down Cathie Wood Stock Bounce Back? ↗

October 17, 2024

An updated version of Exact Sciences' key product just got regulatory approval. That could help the healthcare stock stage a comeback.

Via The Motley Fool

FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test ↗

October 04, 2024

Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in...

Via Benzinga

Exact Sciences Stock Rises After FDA Signs Off On New Cologuard ↗

October 04, 2024

The company is soon to launch its next-generation colon cancer screening tool.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 18, 2024

Via Benzinga

Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗

September 15, 2024

These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings.

Via Benzinga

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 12, 2024

Via Benzinga

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

August 23, 2024

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

Via News Direct

9 Health Care Stocks Whale Activity In Today's Session ↗

August 13, 2024

Via Benzinga

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio? ↗

August 04, 2024

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....

Via Benzinga

Crude Oil Moves Lower; Moderna Shares Plunge ↗

August 01, 2024

Via Benzinga

Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July ↗

August 01, 2024

Via Benzinga

Topics Stocks

Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday ↗

August 01, 2024

Via Benzinga

Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat ↗

August 01, 2024

The company expects stronger second-half sales vs. the first half of 2024.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.